New tool combining evolution and AI predicts prostate cancer recurrence more than a decade ahead 11 Jul 2024 Combining the principles of evolution with artificial intelligence (AI), scientists have proposed a new way to predict the chance of prostate cancer returning. In a recent study, they harnessed computational methods to capture specific tumour measurements relating to the tumour’s ability to change over time. They then showed that these measurements correlate with disease recurrence more than a decade after the initial diagnosis. Find out more Show/Hide
Her Majesty The Queen presents cancer researchers with prize at Buckingham Palace 22 Feb 2024 Earlier today, researchers from The Institute of Cancer Research, London, received a prestigious Queen’s Anniversary Prize on behalf of the institute, in recognition of its transformational breast cancer research programme. Find out more Show/Hide
We must not rush to implement new genetic screening programmes, experts warn 15 Jan 2024 There is a danger that population genetic screening programmes may be introduced without the necessary scrutiny and rigour that is usually applied when screening programmes are put into effect, experts have warned. Find out more Show/Hide
Experts call for genetic testing to personalise treatment for all children assessed for new cancer treatments 26 Sep 2018
World-leading cancer researchers first in UK to receive NovaSeq - the latest genome sequencing technology 13 Jul 2017